参考文献/References:
[1] Consensus development conference:diagnosis,prophylaxis,and treatment of osteoporosis[J].Am J Med,1993,94(6):646-650.DOI:10.1016/0002-9343(93)90218-e.
[2] 第七次全国人口普查公报[1](第五号)——人口年龄构成情况[EB/OL].[2021-05-11].http://www.stats.gov.cn/ztjc/zdtjgz/zgrkpc/dqcrkpc/ggl/202105/t20210519_1817698.html.
[3] 中国疾病预防控制中心慢性非传染性疾病预防控制中心,中华医学会骨质疏松和骨矿盐疾病分会.中国骨质疏松症流行病学调查报告(2018)[M].北京:人民卫生出版社,2021.
[4] Wang L,Yu W,Yin X,et al.Prevalence of osteoporosis and fracture in China:the China osteoporosis prevalence study[J].JAMA Netw Open,2021,4(8):e2121106.DOI:10.1001/ jamanetworkopen.2021.21106.
[5] Zeng Q,Li N,Wang Q,et al.The prevalence of osteoporosis in China,a nationwide,multicent er DXA survey[J].J Bone Miner Res,2019.34(10):1789-1797.DOI:10.1002/jbmr.3757.
[6] Xu L,Lu A,Zhao X,et al.Very low rates of hip fracture in Beijing,people's republic of China the Beijing osteoporosis project[J].Am J Epidemiol,1996,144(9):901-907.DOI:10.1093/oxford journals.aje.a009024.
[7] Xia WB,He SL,Xu L,et al.Rapidly increasing rates of hip fracture in Beijing,China[J].J Bone Miner Res,2012,27(1):125-129.DOI:10.1002/jbmr.519.
[8] Zhang C,Feng J,Wang S,et al.Incidence of and trends in hip fracture among adults in urban China:A nationwide retrospective cohort study[J].PLoS Med,2020,17(8):e1003180.DOI:10.1371/journal.pmed.1003180.
[9] Ling X,Cummings SR,Mingwei Q,et al.Vertebral fractures in Beijing,China:the Beijing Osteoporosis Project[J].J Bone Miner Res,2000,15(10):2019-25.DOI:10.1359/jbmr.2000.15.10.2019.
[10] Cui L,Chen L,Xia W,et al.Vertebral fracture in postmenopausal Chinese women:a population-based study[J].Osteoporos Int,2017,28(9):2583-2590.DOI:10.1007/s00198-017-4085-1.
[11] Gao C,Xu Y,Li L,et al.Prevalence of osteoporotic vertebral fracture among community-dwelling elderly in Shanghai[J].Chin Med J(Engl),2019,132(14):1749-1751.DOI:10.1097/CM9.0000000000000332.
[12] Keene GS,Parker MJ,Pryor GA.Mortality and morbidity after hip fractures[J].BMJ,1993,307(6914):1248-1250.DOI:10.1136/bmj.307.6914.1248.
[13] Osnes EK,Lofthus CM,Meyer HE,et al.Consequences of hip fracture on activities of daily life and residential needs[J].Osteoporos Int,2004,15(7):567-574.DOI:10.1007/s00198-003-1583-0.
[14] Si L,Winzenberg TM,Jiang Q,et al.Projection of osteoporosis-related fractures and costs in China:2010-2050[J].Osteoporos Int,2015,26(7):1929-1937.DOI:10.1007/s00198-015-3093-2.
[15] 国务院办公厅关于印发中国防治慢性病中长期规划(2017—2025年)的通知[EB/OL].[2017-02-14].http://www.gov.cn/zhengce/content/2017-02/14/content_5167886.htm.
[16] 关于印发全民健康生活方式行动方案(2017—2025年)的通知[EB/OL].[2017-04-27].http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=e73c1934c7f84c709e445f01 bf832b17.
[17] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中华骨质疏松和骨矿盐疾病杂志,2017,10(5):413-444.DOI:10.3969/j.issn.1674-2591.2017.05.002.
[18] Majumdar SR,Kim N,Colman I,et al.Incidental vertebral fractures discovered with chest radiography in the emergency department:prevalence,recognition,and osteoporosis management in a cohort of elderly patients[J].Arch Intern Med,2005,165(8):905-909.DOI:10.1001/archinte.165.8.905.
[19] 余卫,姚金鹏,林强,等.胸侧位像椎体压缩骨折诊断忽视原因浅析[J].中华放射学杂志,2010,44(5):504-507.DOI:10.3760/cma.j.issn.1005-1201.2010.05.013.
[20] Siris ES,Adler R,Bilezikian J,et al.The clinical diagnosis of osteoporosis:a position statement from the National Bone Health Alliance Working Group[J].Osteoporos Int,2014,25(5):1439-1443.DOI:10.1007/s00198-014-2655-z.
[21] Kanis JA,Cooper C,Rizzoli R,et al.European guidance for the diagnosis and management of osteoporosis in postmenopausal women[J].Osteoporos Int,2019,30(1):3-44.DOI:10.1007/s00198-018-4704-5.
[22] Liu S,Chen R,Ding N,et al.Setting the new FRAX reference threshold without bone mineral density in Chinese postmenopausal women[J].J Endocrinol Invest,2021,44(2):347-352.DOI:10.1007/s40618-020-01315-4.
[23] Cui L,He T,Jiang Y,et al.Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China:a cost-effectiveness analysis based on real-world data[J].Osteoporos Int,2020,31(2):307-316.DOI:10.1007/s00198-019-05173-6.
[24] van Geel TA,van Helden S,Geusens PP,et al.Clinical subsequent fractures cluster in time after first fractures[J].Ann Rheum Dis,2009,68(1):99-102.DOI:10.1136/ard.2008.092775.
[25] Kanis JA,Cooper C,Rizzoli R,et al.European guidance for the diagnosis and management of osteoporosis in postmenopausal women[J].Osteoporos Int,2019,30(1):3-44.DOI:10.1007/s00198-018-4704-5.
[26] Kendler DLMarin F,Zerbini CAF,et al.Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis(VERO):a multicentre,double-blind,double-dummy,randomised controlled trial[J].Lancet,2018,391(10117):230-240.DOI:10.1016/S0140-6736(17)32137-2.
[27] Saag KG,Petersen J,Brandi ML,et al.Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis[J].N Engl J Med,2017,377(15):1417-1427.DOI:10.1056/NEJMoa1708322.
[28] Akesson K,Marsh D,Mitchell PJ,et al.Capture the fracture:a best practice framework and global campaign to break the fragility fracture cycle[J].Osteoporos Int,2013,24(8):2135-2152.DOI:10.1007/s00198-013-2348-z.
[29] 夏维波.开展“骨折联络服务”,减少再发骨折[J].中华骨质疏松和骨矿盐疾病杂志,2016,9(1):1-6.DOI:10.3969/j.issn.1674-2591.2016.01.001.